StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Merck (MRK) Announces FDA Approval of Expanded Monotherapy Label for its KEYTRUDA
April 11, 2019 5:45 PM
Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced that the U.S. Food and Drug ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Corporate News
FDA
Management Comments
Next Articles
FDA Approves Expanded Monotherapy Label for Merck’s KEYTRUDA® (pembrolizumab)
April 11, 2019 5:45 PM